Iris E. Verhagen

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials

Ruben P. A. van Eijk, Henk-Jan Westeneng, Stavros Nikolakopoulos et al. · Neurology · 2019 · 103 citations · Full text

Public Health, Biostatistics, Neurology +16

Sex differences in prevalence of migraine trigger factors: A cross-sectional study

Daphne S. van Casteren, Iris E. Verhagen, Gerrit L.J. Onderwater et al. · Cephalalgia · 2020 · 73 citations · Full text

Medicine, Neurology, Individual Differences +15

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary

Daphne S. van Casteren, Iris E. Verhagen, Britt W. H. van der Arend et al. · Neurology · 2021 · 64 citations · Full text

Medicine, Gynecology, Psychiatry +17

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study

Iris E. Verhagen, Daphne S. van Casteren, Simone de Vries Lentsch et al. · Cephalalgia · 2021 · 63 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +11

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study

Simone de Vries Lentsch, Iris E. Verhagen, Thomas C. van den Hoek et al. · European Journal of Neurology · 2021 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17